InsidersTradesSigma
Track the 东诚药业 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 东诚药业 has logged 1 insider filings. Market capitalisation: €10.5bn. The latest transaction was reported on 17 May 2022 (Sale). Among the most active insiders: 吴丽娣. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
东诚药业是一家专注于健康和制药领域的公司，专门从事药物的研发。该公司在 XSHE 市场上市。